Operating Margin: Operating margin measurement of what proportion of a company's revenue is left over after paying for variable costs of production such as wages, raw materials, etc. Calculated as: Operating Income / Total Revenues
Kura Oncology, Inc. (KURA) had Operating Margin of -475.31% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$15.29M |
|
$-66.12M |
|
-- |
|
$15.29M |
|
$87.95M |
|
$-72.67M |
|
$6.54M |
|
$-66.12M |
|
$-66.12M |
|
$-66.12M |
|
$-66.12M |
|
$-66.12M |
|
$-66.12M |
|
$-72.67M |
|
$-74.96M |
|
87.59M |
|
87.59M |
|
$-0.75 |
|
$-0.75 |
|
| Balance Sheet Financials | |
$660.08M |
|
$3.91M |
|
$22.35M |
|
$682.42M |
|
$107.17M |
|
$6.51M |
|
$269.76M |
|
$376.94M |
|
$305.49M |
|
$305.49M |
|
$305.49M |
|
86.80M |
|
| Cash Flow Statement Financials | |
$-100.70M |
|
$-42.47M |
|
$0.66M |
|
$224.46M |
|
$81.95M |
|
$-142.51M |
|
$14.79M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.16 |
|
-- |
|
-- |
|
0.02 |
|
0.03 |
|
100.00% |
|
|
Operating Margin |
-475.31% |
-475.31% |
|
-- |
|
-432.51% |
|
-432.51% |
|
$-102.45M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
3.34 |
|
26.93 |
|
-21.64% |
|
-21.64% |
|
-9.69% |
|
-21.19% |
|
$3.52 |
|
$-1.17 |
|
$-1.15 |
|